ImmunoTheragnostics Incorporated
	Developer of therapeutic and prognostic equipments. The company engages in research, development and commercialization of exosome-based clinical diagnostic arrays for women\'s health as well as for cardiovascular diseases and cancer.
	['', 'prognostic equipment', ' ', 'diagnostic assays', ' ', 'cancer prevention', ' ', 'response monitoring', '']
Lumativa
	Developer of anti-infectives for women’s health. The company engages in the development and marketing of new drugs to combat infections for women’s health, addressing areas of high unmet medical need.
	['FemiFect ', 'anti-infective', ' gynaecologists']
Corvas
	Manufacturer and developer of therapeutic agents for the prevention and treatment of cardiovascular and inflammatory diseases. The company also undertakes cancer research programs.
	['biotherapeutics ', 'cardiovascular disease', ' ', 'drug candidate', '']
Sterix
	Operator of a biopharmaceutical company. The company specializes in the research and development of a new generation of steroid-based therapeutic products for use in oncology and metabolism or endocrine-related diseases, including cancer treatments, women\'s health, diabetes and hormone-associated diseases.
	['steroid metabolism endocrine']
ZOLL LIFEBRIDGE
	Supplier of life support systems for the acute medical care in the area of cardiovascular diseases. The company develops heart-lung machine that allows doctors to substitute the patient’s cardiovascular system and save them from death in cardiogenic shock.
	['', 'life support system', ' ', 'heart-lung machine', ' ', 'cardiovascular system', ' ', 'medical care', '']
Angio B
	Developer and provider of drugs concentrating on treatment of cardiovascular diseases and peripheral ischemic disorders. The company engages in research and development of drugs concentrating on treatment of cardiovascular diseases and peripheral ischemic disorders.
	['', 'cardiovascular disease', ' ', 'peripheral ischemic disorder', ' ', 'development of drug', '']
Adnexus Therapeutics
	Developer of Adnectins biologics/medicines in the United States. The company\'s product candidates include Angiocept/CT-322, an anti-angiogenesis agent for treating cancer that blocks the VEGFR-2 pathway; and other Adnectin therapies for the treatment of oncology, immunology, and cardiovascular diseases.
	['', 'drug discovey', ' ', 'anti-angiogenesis agent', ' ', 'treatment of oncology', '']
